To test whether knockdown of STAT1 improves phagocytic activity of BMDMs from the different subgroups of AML, the cells were treated with fludarabine or STAT1 siRNA in the presence or absence of CYLD siRNA. Here, CYLD is linked to acute myeloid leukemia.